Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:NSC
NYSE:NSCTransportation

A Look At Norfolk Southern (NSC) Valuation After The Jaguar Freight Partnership Announcement

Why the Jaguar partnership matters for Norfolk Southern stock Norfolk Southern (NSC) is back in focus after announcing a partnership with Jaguar Transport Holdings to handle local switching, run its Doraville transload terminal, and invest in added freight capacity in northeast Atlanta. The agreement centers on first and final mile service, with Jaguar expected to upgrade infrastructure at Doraville to support new freight volumes, increased transloading capacity, and smoother connections for...
TSX:HBM
TSX:HBMMetals and Mining

Hudbay Minerals (TSX:HBM) Valuation Check After Strong Momentum And Copper World Growth Plans

Hudbay Minerals stock at a glance Hudbay Minerals (TSX:HBM) has drawn investor attention after recent share price moves, including a 1 day return of around a 1% decline and gains over the week, month and past 3 months. See our latest analysis for Hudbay Minerals. The recent 7.8% 7 day share price return and 17.6% year to date share price return at around CA$32.45 sit alongside a very large 1 year total shareholder return. This suggests momentum has been strong rather than fading. If you are...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

A Look At Ardelyx (ARDX) Valuation After The Appointment Of New Chief Medical Officer

Ardelyx (ARDX) has drawn fresh attention after appointing Rajani Dinavahi, MD, as Chief Medical Officer. This leadership change puts clinical development and regulatory execution squarely in focus for current and prospective shareholders. See our latest analysis for Ardelyx. The latest leadership news arrives after a mixed period for the stock, with a 44.24% 1 year total shareholder return contrasting with a 20.80% decline in the 90 day share price return. This suggests that momentum has...
SWX:LOGN
SWX:LOGNTech

Assessing Logitech International (SWX:LOGN) Valuation After Recent Share Price Weakness

Logitech International stock: understanding recent performance Logitech International (SWX:LOGN) has drawn investor attention after a recent pullback, with the share price showing a 3.4% decline over the past day and a 1.7% move lower over the past week. See our latest analysis for Logitech International. That short term weakness sits against a mixed backdrop, with the 90 day share price return of 6.8% decline and a year to date share price return of 9.3% decline contrasting with a 1 year...
NYSE:PG
NYSE:PGHousehold Products

A Look At Procter & Gamble (PG) Valuation After Mr. Clean PRO Launch And Expanded WNBA Partnership

Procter & Gamble (PG) has just expanded its brand playbook, rolling out the Mr. Clean PRO commercial cleaning line alongside a multi-year WNBA partnership. This combination is refocusing investor attention on how the company grows. See our latest analysis for Procter & Gamble. Despite the Mr. Clean PRO launch and the expanded WNBA partnership keeping Procter & Gamble in the headlines, the share price has had a mixed run, with a 7-day share price return of 2.47% but a 30-day share price return...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

New Commercial Chief and Closed-Loop Progress Might Change The Case For Investing In Insulet (PODD)

In March 2026, Insulet Corporation appointed veteran medtech executive Mike Panos as Executive Vice President and Chief Commercial Officer, putting him in charge of the company’s global commercial strategy and execution. This leadership change comes shortly after encouraging clinical data on Insulet’s fully closed-loop insulin delivery system for type 2 diabetes, highlighting a simultaneous push on both commercial and product fronts. We’ll now examine how Mike Panos’s appointment to lead...
SWX:NOVN
SWX:NOVNPharmaceuticals

A Look At Novartis (SWX:NOVN) Valuation After Fabhalta Phase III IgA Nephropathy Results

Novartis (SWX:NOVN) is back in focus after releasing final two year Phase III data for Fabhalta in IgA nephropathy, which showed clinically meaningful kidney outcomes versus placebo and supports an ongoing FDA priority review. See our latest analysis for Novartis. The Fabhalta readout appears to be feeding into sentiment, with the share price at CHF122.18 and a 90 day share price return of 7.14%. The 1 year total shareholder return of 48.62% contrasts with a more modest 12.61% year to date...
XTRA:EVK
XTRA:EVKChemicals

Is It Time To Reassess Evonik Industries (XTRA:EVK) After Its Recent Share Price Surge?

Wondering if Evonik Industries at €17.20 is offering real value or just a value trap? This article breaks down what the current price might be saying about the stock. Over shorter time frames the share price has moved sharply, with returns of 3.8% over 7 days, 23.9% over 30 days, 29.2% year to date and 2.1% over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on Evonik Industries as a chemicals group where investors are...
NasdaqCM:SMPL
NasdaqCM:SMPLFood

Simply Good Foods (SMPL) One Off Loss And Margin Compression Test Bullish Narratives

Simply Good Foods (SMPL) has put fresh numbers on the board for Q2 2026, with Q1 revenue of $340.2 million and basic EPS of $0.26 setting the tone against a backdrop where trailing 12 month EPS stands at $0.91 on revenue of $1.45 billion. Over the last few reported quarters, revenue has moved between $341.3 million and $380.9 million while basic EPS has ranged from a loss of $0.12 to a profit of $0.41, giving investors a clear view of how earnings and sales have tracked through recent...
NYSE:LMND
NYSE:LMNDInsurance

Is Lemonade (LMND) Using South Carolina Renters Launch to Prove Its AI Insurance Model?

Lemonade, Inc. recently launched its fully digital renters insurance product in South Carolina, allowing renters to quote, buy, adjust coverage, and file claims through its app while offering protection for personal property, liability, medical payments, and loss of use. This rollout comes as Lemonade reports a very large year-on-year jump in website traffic to 9.46 million quarterly visits, underscoring growing customer engagement with its app-based insurance model. We’ll now examine how...
NYSE:LH
NYSE:LHHealthcare

Labcorp Expands Specialized Testing As AI Efficiencies Shape Valuation Story

Labcorp Holdings, NYSE:LH, is expanding into specialized diagnostic testing, including oncology and neurology, through recent acquisitions and product launches. The company is reporting operational improvements and cost savings linked to business optimization and AI driven initiatives. These changes reflect a sharpened focus on higher growth testing segments and more efficient operations. Labcorp Holdings, NYSE:LH, enters this phase of expansion with its shares at $273.26 and a 26.3% return...
NYSE:RBLX
NYSE:RBLXEntertainment

A Look At Roblox’s Valuation As Analyst Revisions And Softer Q2 Bookings Stir Fresh Debate

Recent analyst moves on Roblox (RBLX), including reaffirmed buy and overweight ratings along with reduced price targets and softer Q2 bookings projections, have put the stock in focus for investors assessing near term risk and reward. See our latest analysis for Roblox. The recent pullback, with a 7 day share price return of 8.22% and a year to date share price return of 31.85% decline from US$55.17, comes after softer Q2 bookings projections and mixed short term trading signals. At the same...
NasdaqGS:UAL
NasdaqGS:UALAirlines

Is United Airlines (UAL) Using Premium Perks to Offset Governance Pushback from Activist Investors?

In early April 2026, United Airlines Holdings, Inc. faced investor activism as shareholder John Chevedden submitted a proposal to allow action by written consent, while the company simultaneously urged investors to vote against it ahead of the May 19, 2026 annual meeting. At the same time, United advanced a premium-focused transformation that includes a tentative industry-leading flight attendant agreement, higher checked-bag fees, and new premium fare tiers, reshaping how it balances...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Is It Time To Reassess Amneal Pharmaceuticals (AMRX) After Its Strong Multi Year Share Price Run?

If you are wondering whether Amneal Pharmaceuticals' current share price reflects its true worth, the recent returns give you plenty to think about. The stock last closed at US$12.80, with a 2.6% return over 7 days, a 4.1% decline over 30 days, a 1.1% return year to date, and a very strong 83.6% return over the past year, alongside a very large gain over 3 years and a 116.9% return over 5 years. Recent price moves have put more attention on how Amneal Pharmaceuticals is being valued and what...
NYSE:TRV
NYSE:TRVInsurance

Is It Too Late To Consider Travelers Companies (TRV) After Strong Multi‑Year Share Price Gains?

Investors may be wondering whether Travelers Companies, at around its recent US$303.23 close, still offers value or if most of the potential upside has already been priced in. The stock has posted returns of 3.1% over the last 7 days, 0.3% over 30 days, 6.3% year to date and 25.6% over 1 year, with longer-term returns of 85.0% over 3 years and 116.8% over 5 years. Recent coverage has focused on Travelers Companies as a large US insurer and how investors are reassessing established insurance...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Assessing Zoetis (ZTS) Valuation After Earnings Growth And Shareholder Rights Activism

Why Zoetis stock is back in focus after fresh activism and recent earnings Zoetis (ZTS) is drawing attention after reporting organic revenue and adjusted net income growth. The company is also facing a new shareholder rights proposal that management is urging investors to vote against at the upcoming annual meeting. See our latest analysis for Zoetis. The fresh activism around shareholder rights arrives after a weaker run for investors, with a 1-year total shareholder return of 17.19% and a...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Is Viavi Solutions (VIAV) Quietly Building a Maritime Edge in Secure Navigation Technology?

In early April 2026, Ground Control announced a partnership with Viavi Solutions to integrate Viavi’s Secure µPNT STL-1000 receiver into the RockFLEET Assured maritime asset tracking and assured navigation system for GNSS-denied environments. This collaboration highlights Viavi’s role in providing resilient, secure timing and navigation technology for critical missions where traditional satellite signals may be disrupted. We’ll now examine how this assured navigation partnership, focused on...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

Byrna Technologies (BYRN) Net Margin Drop Challenges Bullish Growth Narratives Ahead Of Q1 2026

Byrna Technologies (BYRN) has just opened its Q1 2026 earnings season narrative following a Q4 2025 print that showed total revenue of US$35.2 million and basic EPS of US$0.15, with trailing twelve month revenue at US$118.1 million and basic EPS of US$0.43. Over recent quarters the company has seen revenue move from US$27.9 million in Q4 2024 to US$35.2 million in Q4 2025, while basic EPS shifted from US$0.43 to US$0.15. This sets up a results story where investors are likely to focus on how...
ASX:RSG
ASX:RSGMetals and Mining

Assessing Resolute Mining's Valuation After New Guinea Gold MoU Expands West African Growth Path

Resolute Mining (ASX:RSG) has signed a Memorandum of Understanding with Nimba Mining Company and the Government of Guinea to assess and potentially co develop gold projects in one of West Africa's key gold regions. See our latest analysis for Resolute Mining. The MoU arrives after a strong period for the stock, with a 7 day share price return of 7.9% and a year to date share price return of 21.9%. The 1 year total shareholder return of about 2.4x signals powerful longer term momentum. If this...
ENXTPA:SU
ENXTPA:SUElectrical

Schneider Electric (ENXTPA:SU) Valuation Check After Strong Multi‑Year Shareholder Returns

What recent performance data says about Schneider Electric Schneider Electric (ENXTPA:SU) has drawn attention after a period where the share price return sits around 0.1% over the past day, about 8.4% over the past week, and roughly 8% year to date. See our latest analysis for Schneider Electric. That short term momentum sits alongside a 90 day share price return of 8.8%, while the 1 year total shareholder return of 32.5% and 5 year total shareholder return of 108.6% point to steady...
ENXTPA:DG
ENXTPA:DGConstruction

Is It Too Late To Consider Vinci (ENXTPA:DG) After Its Strong 1 Year Rally?

If you are wondering whether Vinci's current share price offers value or is already pricing in the good news, it helps to break the story down into hard numbers and clear benchmarks. Vinci's shares recently closed at €136.90, with returns of 4.0% over 7 days, 5.1% over 30 days, 13.0% year to date and 27.4% over 1 year, as well as 41.1% over 3 years and 82.9% over 5 years, which can change how the market views both its potential and its risks. Recent coverage around Vinci has focused on...